Kraig Biocraft Laboratories, Inc.
KBLB
$0.09
$0.002.82%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.51M | -726.10K | -600.00K | -851.70K | -433.20K |
| Total Depreciation and Amortization | 21.50K | 36.90K | 5.70K | 19.80K | 6.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 874.00K | 4.50K | -58.90K | 54.10K | -60.60K |
| Change in Net Operating Assets | 152.20K | 241.70K | 218.70K | 265.30K | 160.90K |
| Cash from Operations | -461.90K | -443.10K | -434.50K | -512.50K | -326.30K |
| Capital Expenditure | 0.00 | -3.80K | -- | -4.20K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 222.80K | 147.20K | -- | -- | -- |
| Cash from Investing | 222.80K | 143.50K | -- | -4.20K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -50.00K | -- | -- | 0.00 | -5.20K |
| Issuance of Common Stock | -- | 856.40K | -- | -- | -- |
| Repurchase of Common Stock | -856.40K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.93M | -168.20K | 158.20K | -- | -- |
| Cash from Financing | 1.02M | 688.10K | 158.20K | 0.00 | -5.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 780.20K | 388.50K | -276.30K | -516.80K | -331.50K |